We are creating a new paradigm based on the value of real-time PCR and multiplex assays. Our technology makes it possible to detect hundreds of targets on a single platform.
Real-time PCR combines amplification and detection into a single step. The short turnaround time (TAT) and Seegene’s high multiplex assays enable the detection of multiple targets in a single assay.
Learn more about all the assays we offer—search by disease type below.
The Allplex™ 2019-nCoV (SARS-CoV-2) Assay is available in the US under Emergency Use Authorization (EUA).
The Seegene Novaplex™ assays are Research Use Only (RUO), real-time reverse transcriptase polymerase chain reaction (RT-PCR) tests that maximize test efficiency. These assays simultaneously test for multiple targets efficiently with reduced reagent costs and minimal labor required.
*Novaplex™ Assays are For Research Use Only. Not for Use in Diagnostic Procedures.
**Allplex™ 2019-nCoV Assay is for Emergency Use Authorization in the U.S.